Anthony Howell - Concepedia

Author

Anthony Howell

Also Known As

A Buzdar, A HOWELL, A Howell, A. ALEXANDER HOWELL, A. Alexander Howell, A. HOWELL, A. Howell, A.H Howell, A.H. Howell, ACTB Investigators

1.1K

Publications

61.8K

Citations

130

H-Index

272

Concepts

All Affiliations

University of Manchester The Christie Hospital Manchester Academic Health Science Centre Cancer Research UK Manchester Institute The Christie NHS Foundation Trust

About

Anthony Howell is an author at University of Manchester specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	73	225	23.5K
2	Health Sciences	21	32	5.5K
3	Education	2	2	38
4	Engineering	1	1	51
5	Natural Sciences	1	1	16

Anthony Howell

425

Publications

50.1K

Citations

116

H-Index

Page 1

	Year	Citations
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Anthony Howell, Jack Cuzick, M Baum, The Lancet Breast OncologyMedicineClinical TrialsAdjuvant TreatmentBreast Cancer	2005	2.3K
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Jack Cuzick, Ivana Šestak, Michael Baum, The Lancet Oncology Breast OncologyOncologyAtac TrialPharmacologyAdjuvant Treatment	2010	1.7K
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, The American Journal of Human Genetics	2018	1.1K
Adjuvant Docetaxel for Node-Positive Breast Cancer Miguel Martín, Tadeusz Pieńkowski, John R. Mackey, New England Journal of Medicine	2005	950
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Lee S. Rosen, David Gordon, Mary Kaminski, PubMed	2002	899
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma Lee S. Rosen, David Gordon, Mary Kaminski, Cancer	2003	872
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women Michelle Harvie, Mary Pegington, Mark P. Mattson, International Journal of Obesity ObesityMetabolic SyndromeNutritionContinuous Energy RestrictionLifestyle Modification	2010	797
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial J Cuzick, JF Forbes, Rob Edwards, The Lancet Breast OncologyPreventive MedicineCancer ScreeningGlobal HealthMedicine	2002	742
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer Jack Cuzick, Mitch Dowsett, Sílvia Pineda, Journal of Clinical Oncology	2011	737
Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study Mitch Dowsett, Jack Cuzick, Christopher Wale, Journal of Clinical Oncology	2010	718

Page 1